Panacea Biotec Limited — Important, 04-03-2025: Updates

During February 2025, Panacea Biotec Ltd. reported a total of 6,10,94,525 shares dematerialized, comprising 5,28,63,975 shares via the National Securities Depository Limited (NSDL) and 82,30,550 shares through the Central Depository Services (India) Limited (CDSL). This marks a net increase of 2,000 shares from the prior month's total.

The company's consistent efforts to enhance liquidity through the dematerialization process reflect a focus on improving shareholder accessibility and potential market engagement. Investors should observe this trend as it may indicate growing interest and participation in the company's equity, presenting a positive outlook for future trading dynamics.